Genmab A/S (GNMSF)
OTCMKTS
· Delayed Price · Currency is USD
224.30
+6.17 (2.83%)
Jun 11, 2025, 12:39 PM EDT
Genmab Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 3,231 | 2,988 | 2,443 | 2,084 | 1,287 | 1,662 | Upgrade
|
| Revenue Growth (YoY) | 25.44% | 22.32% | 17.23% | 61.88% | -22.52% | 106.20% | Upgrade
|
| Cost of Revenue | 157.72 | 136.74 | 33.52 | - | - | - | Upgrade
|
| Gross Profit | 3,073 | 2,852 | 2,410 | 2,084 | 1,287 | 1,662 | Upgrade
|
| Selling, General & Admin | 550.13 | 526.14 | 488.94 | 384.48 | 196.24 | 108.63 | Upgrade
|
| Research & Development | 1,425 | 1,343 | 1,132 | 799.14 | 639.51 | 515.54 | Upgrade
|
| Operating Expenses | 1,976 | 1,869 | 1,620 | 1,184 | 835.75 | 624.17 | Upgrade
|
| Operating Income | 1,098 | 982.72 | 789.09 | 900.43 | 451.68 | 1,037 | Upgrade
|
| Interest Expense | -18.39 | -16.66 | -10.38 | -5.6 | -1.99 | -1.64 | Upgrade
|
| Interest & Investment Income | 131.17 | 138.13 | 145.63 | 46.55 | 30.13 | 30.24 | Upgrade
|
| Currency Exchange Gain (Loss) | 159.01 | 185.88 | -131.84 | 151.01 | 224.85 | -239.28 | Upgrade
|
| EBT Excluding Unusual Items | 1,369 | 1,290 | 792.5 | 1,092 | 704.67 | 826.8 | Upgrade
|
| Merger & Restructuring Charges | -43.47 | -41.65 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 7.79 | 34.29 | 43.45 | -94.54 | -105.39 | 143.47 | Upgrade
|
| Asset Writedown | -11.01 | -10.55 | - | - | - | - | Upgrade
|
| Pretax Income | 1,323 | 1,272 | 835.95 | 997.85 | 599.28 | 970.27 | Upgrade
|
| Income Tax Expense | 183.25 | 183.25 | 190.56 | 214.51 | 146.99 | 188.34 | Upgrade
|
| Net Income | 1,140 | 1,089 | 645.39 | 783.33 | 452.29 | 781.94 | Upgrade
|
| Net Income to Common | 1,140 | 1,089 | 645.39 | 783.33 | 452.29 | 781.94 | Upgrade
|
| Net Income Growth | 44.05% | 68.72% | -17.61% | 73.19% | -42.16% | 140.38% | Upgrade
|
| Shares Outstanding (Basic) | 62 | 64 | 65 | 65 | 65 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 62 | 65 | 66 | 66 | 66 | 66 | Upgrade
|
| Shares Change (YoY) | -61.77% | -1.94% | -0.14% | -0.06% | 0.24% | 3.53% | Upgrade
|
| EPS (Basic) | 18.37 | 16.96 | 9.88 | 11.98 | 6.92 | 12.00 | Upgrade
|
| EPS (Diluted) | 18.36 | 16.85 | 9.79 | 11.87 | 6.85 | 11.87 | Upgrade
|
| EPS Growth | 276.80% | 72.08% | -17.49% | 73.29% | -42.30% | 132.20% | Upgrade
|
| Free Cash Flow | 1,159 | 1,053 | 1,040 | 516.52 | 302.24 | 1,007 | Upgrade
|
| Free Cash Flow Per Share | 18.67 | 16.29 | 15.78 | 7.83 | 4.58 | 15.28 | Upgrade
|
| Gross Margin | 95.12% | 95.42% | 98.63% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | 33.97% | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade
|
| Profit Margin | 35.27% | 36.44% | 26.42% | 37.59% | 35.13% | 47.06% | Upgrade
|
| Free Cash Flow Margin | 35.87% | 35.23% | 42.58% | 24.79% | 23.48% | 60.59% | Upgrade
|
| EBITDA | 1,145 | 1,026 | 819.93 | 941.81 | 481.35 | 1,075 | Upgrade
|
| EBITDA Margin | 35.43% | 34.33% | 33.56% | 45.19% | 37.39% | 64.71% | Upgrade
|
| D&A For EBITDA | 47.06 | 43.17 | 30.85 | 41.38 | 29.67 | 37.8 | Upgrade
|
| EBIT | 1,098 | 982.72 | 789.09 | 900.43 | 451.68 | 1,037 | Upgrade
|
| EBIT Margin | 33.97% | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade
|
| Effective Tax Rate | 13.85% | 14.40% | 22.80% | 21.50% | 24.53% | 19.41% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.